N790 closed Friday higher at 0.16, an increase of 0% from Thursday's close, completing a monthly decrease of -31.7992% or -0.08. Over the past 12 months, N790 stock lost -86.4167%.
N790 is not paying dividends to its shareholders.
LIR Life Sciences Corp. has completed 1 stock splits, with the recent split occurring on Dec 20, 2024.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on NEO-L (CAD).
Has LIR Life Sciences Corp. ever had a stock split?
LIR Life Sciences Corp. had 1 splits and the recent split was on Dec 20, 2024.
LIR Life Sciences Corp. Profile
Metals & MiningIndustry
MaterialsSector
Dr. Edward Mills Ph.D.CEO
XMUNExchange
-ISIN
USCountry
-Employees
-Last Dividend
-Last Split
-IPO Date
LIR Life Sciences Corp. operates as biopharmaceutical company that develops transdermal delivery system for obesity and metabolic disorders. The company was incorporated in 2024 and is based in Vancouver, Canada.
Contact Information
Address:1505 W 2nd Ave, Vancouver, BC, Canada, V6J 1H2